The range and incidence of adverse events (AEs) related to endoscopic retrograde cholangiopancreatography (ERCP) differ substantially from those related to other endoscopic procedures. Familiarity with these AEs is critical for providing patient information during the consent phase as well as for prophylaxis and management. Adverse events related to sedation, biliary stent obstruction, radiation, infection, and to the endoscopic resection of ampullary neoplasms will not be discussed as they are included in other Guidelines from the European Society of Gastrointestinal Endoscopy (ESGE)
Dumonceau, J., Kapral, C., Aabakken, L., Papanikolaou, I. S., Tringali, A., Vanbiervliet, G., Beyna, T., Dinis-Ribeiro, M., Hritz, I., Mariani, A., Paspatis, G., Radaelli, F., Lakhtakia, S., Veitch, A. M., Van Hooft, J. E., ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, <<ENDOSCOPY>>, 2020; 52 (2): 127-149. [doi:10.1055/a-1075-4080] [http://hdl.handle.net/10807/145263]
ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Tringali, Andrea;
2020
Abstract
The range and incidence of adverse events (AEs) related to endoscopic retrograde cholangiopancreatography (ERCP) differ substantially from those related to other endoscopic procedures. Familiarity with these AEs is critical for providing patient information during the consent phase as well as for prophylaxis and management. Adverse events related to sedation, biliary stent obstruction, radiation, infection, and to the endoscopic resection of ampullary neoplasms will not be discussed as they are included in other Guidelines from the European Society of Gastrointestinal Endoscopy (ESGE)
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
